We studied 14 different treatments and programs for weight loss and here is what we found:
There Are Three Main Approaches to Weight Loss
Diet-Based Programs
These programs, like Weight Watchers and Nutrisystem, emphasize calorie restriction and balanced nutrition to create a caloric deficit while maintaining nutrient intake. By controlling portions and food choices, they seek to reset eating habits and help participants steadily lose weight.
- Pros: They offer structured, guided plans that simplify meal planning for a wide range of preferences and lifestyles.
- Cons: Can feel restrictive and monotonous over time, potentially leading to diet fatigue or burnout.
Medications
Pharmaceuticals like Orlistat or Semaglutide work by targeting hunger signals or inhibiting fat absorption to reduce caloric intake or cravings. Their impact directly alters the biological processes driving appetite or nutrient processing.
- Pros: Often show faster, significant results, especially beneficial for those with obesity-related health conditions.
- Cons: Potential side effects can limit long-term adherence, and some require a prescription, making them less accessible without medical supervision.
Surgeries
Procedures like gastric bypass, sleeve gastrectomy, and adjustable gastric banding alter the digestive system to limit food intake or reduce nutrient absorption. These irreversible changes fundamentally change the body's physiological response to food.
- Pros: Proven to deliver significant, sustained weight loss, especially effective for severe obesity cases.
Cons: High cost, surgical risks, and potential long-term lifestyle changes can be daunting and demand comprehensive pre- and post-operative support.
When it comes to weight loss, it's less about your age, it is more about your current BMI and current health status.
Ranking Weight Loss Program By Results
Weight loss approaches vary greatly in effectiveness, ranging from diet-based programs like Weight Watchers (-5.1 kg) to surgeries like gastric bypass (-28.6%). Surprisingly, some medications like Tirzepatide (-20.9%) deliver results rivaling surgical procedures, blurring the line between non-invasive and surgical effectiveness.
For someone starting at 200 lbs, surgeries deliver the most drastic results, with BPD/DS leading to an estimated 66.6 lb loss in 2 years, followed by gastric bypass with a 57.2 lb loss over 5 years. Medication-based options like Tirzepatide and Semaglutide offer significant reductions at 41.8 lbs and 29.8 lbs, respectively, over a year. Among diet-based programs, Noom and Jenny Craig rank highest, with losses of 15.28 lbs and 14.6 lbs in a year.
| Program/Treatment | Weight Loss Results | Study Name |
|---|---|---|
Diet-based Programs: Somewhat effective, widely accessible | ||
| Weight Watchers | -5.1 kg (12 months) | Jebb et al., 2011 (n=772) |
| Jenny Craig | -7.3 kg (12 months) | Rock et al., 2010 (n=442) |
| Nutrisystem | -7.5% (3 months) | Foster et al., 2009 (n=69) |
| Noom | -7.64% (52 weeks) | Toro-Ramos et al., 2020 (n=204) |
Medications: Effective but need long-term medical supervision | ||
| Orlistat | -2.9 kg (12 months) | Rucker et al., 2007 (n=10,631) |
| Phentermine | -12.2 kg (36 weeks) | Munro et al., 1968 (n=108) |
| Bupropion/Naltrexone | -6.1% (56 weeks) | Greenway et al., 2010 (n=1,742) |
| Liraglutide (Saxenda) | -8.4% (56 weeks) | Pi-Sunyer et al., 2015 (n=3,731) |
| Semaglutide (Wegovy) | -14.9% (68 weeks) | Wilding et al., 2021 (n=1,961) |
| Tirzepatide (Mounjaro) | -20.9% (72 weeks, 15 mg) | Jastreboff et al., 2022 (n=2,539) |
Surgeries: Best but high risk and strict eligibility | ||
| Gastric Bypass | -28.6% (5 years) | Schauer et al., 2017 (n=134) |
| Sleeve Gastrectomy | -21.7% (5 years) | Schauer et al., 2017 (n=134) |
| Adjustable Gastric Band | -20.7% (2 years) | O'Brien et al., 2013 (n=80) |
| BPD/DS | -33.3% (2 years) | Mingrone et al., 2012 (n=60) |
Ranking Weight Loss Programs By Cost
It is cheaper to gain weight than to lose it. Sadly. When ranking weight loss programs by cost, it's striking how pharmaceutical treatments like tirzepatide can reach over $12,000 annually, rivaling surgical options in expense.
Even popular diet plans like Jenny Craig, with its tiered meal pricing, can end up costing upwards of $9,000 per year for comprehensive options, challenging the assumption that "simple" dietary changes are the cheapest. Intriguingly, generic medications like phentermine/topiramate, despite their low upfront price, offer substantial results at a fraction of the cost, often under $200 a month.
Meanwhile, flexible app-based approaches like Noom offer relative affordability, yet require a mental investment to stick to daily engagement.
| Program/Treatment | Pricing | Monthly Cost | Annual Cost |
|---|---|---|---|
Diet-based Programs: Widest price range | |||
| Weight Watchers (WW) | Digital: Starts at $3.38 per week, Unlimited Workshops + Digital: Starts at $6.92 per week, 1-on-1 Coaching + Digital: Starts at $11.08 per week | $14.7 - $48.0 | $175.8 - $576.0 |
| Jenny Craig | Simple Meal Plan: Starts at $12.99 per day, Essential Meal Plan: Starts at $20.78 per day, Rapid Results Max Weight Loss Plan: Starts at $25.99 per day | $389.7 - $779.7 | $4,676.4 - $9,356.4 |
| Nutrisystem | Basic Plan: Starts at $8.57 per day, Uniquely Yours Plan: Starts at $10.36 per day, Uniquely Yours Max+ Plan: Starts at $12.14 per day | $257.1 - $364.2 | $3,085.2 - $4,370.4 |
| Noom | Monthly: $60/month, 2-month: $99 | $60.0 - $49.5 | $720.0 - $594.0 |
Medications: Expensive if paying out-of-pocket | |||
| Orlistat (Xenical) | $242.76 for 28-day supply | $242.8 | $2,913.1 |
| Phentermine/Topiramate (Qsymia) | $223.44 for 28-day supply | $223.4 | $2,680.8 |
| Bupropion/Naltrexone (Contrave) | $175.00 for 28-day supply | $175.0 | $2,100.0 |
| Semaglutide (Ozempic Injectable) | $1,070.46 for 28-day supply | $1,070.5 | $12,845.5 |
| Semaglutide (Rybelsus Oral) | $999.04 for 28-day supply | $999.0 | $11,988.5 |
| Tirzepatide (Mounjaro) | $1,069.08 for 28-day supply | $1,069.1 | $12,829.0 |
Surgeries: Very expensive but usually covered by insurance if medically necessary | |||
| Gastric Bypass | $23,000 (varies widely) | $23,000 | |
| Sleeve Gastrectomy | $17,000 (varies) | $17,000 | |
| Adjustable Gastric Band | $15,000 (varies) | $15,000 | |
| BPD/DS (Biliopancreatic Diversion with Duodenal Switch) | $27,000 (varies) | $27,000 |
Dollar for the Pound: What's The Best Weight Loss Program by ROI?
To extrapolate weight loss results over a year, we used the clinical trial data provided for each weight loss treatment or program. When the study duration was less than a year, we estimated the weight loss trajectory by assuming a diminishing curve, where initial weight loss rates tend to slow down over time as participants approach a plateau. Here's a brief outline of our approach:
Where weight loss was given as a percentage of initial body weight, we calculated pounds lost using a starting weight of 200 lbs. For studies with durations shorter than a year, we approximated a year's result by adjusting for potential diminishing returns. For medications and surgeries where longer-term data were available, the calculations were annualized to match a yearly framework.
| Name | Clinical Results | Extrapolated Weight Loss First Year | Cost per Pound Lost ($/lb) |
|---|---|---|---|
Diet-based Programs: Highly varied ROI, high will power required | |||
| Weight Watchers (WW) | -5.1 kg (12 months) | 11.2 lbs | $15.7 - $51.4 |
| Jenny Craig | -7.3 kg (12 months) | 16.1 lbs | $290.3 - $581.2 |
| Nutrisystem | -7.5% (3 months) | 15.0 lbs | $205.7 - $291.4 |
| Noom | -7.64% (52 weeks) | 15.3 lbs | $38.8 - $47.1 |
Medications: Few hundreds dollar per lb reduction, long-term cost is a concern | |||
| Orlistat (Xenical) | -2.9 kg (12 months) | 6.4 lbs | $455.2 |
| Phentermine/Topiramate (Qsymia) | -12.2 kg (36 weeks) | 26.9 lbs | $99.7 |
| Bupropion/Naltrexone (Contrave) | -6.1% (56 weeks) | 12.2 lbs | $172.1 |
| Semaglutide (Ozempic) | -14.9% (68 weeks) | ~26.0 lbs (yearly) | $494.1 |
| Semaglutide (Rybelsus) | -14.9% (68 weeks) | ~26.0 lbs (yearly) | $461.1 |
| Tirzepatide (Mounjaro) | -20.9% (72 weeks, 15 mg) | ~38.0 lbs (yearly) | $337.6 |
Surgeries: $1K-$2K per lb reduction, but permanent | |||
| Gastric Bypass | -28.6% (5 years) | ~11.4 lbs (annualized) | ~$2,017.5 |
| Sleeve Gastrectomy | -21.7% (5 years) | ~8.7 lbs (annualized) | ~$1,954.0 |
| Adjustable Gastric Band | -20.7% (2 years) | ~20.7 lbs (yearly) | ~$724.6 |
| BPD/DS | -33.3% (2 years) | ~33.3 lbs (yearly) | ~$810.8 |
Weight Regaining & Long-term Effectiveness: Comparing different approaches
When it comes to the long-term effectiveness of weight loss approaches, it's crucial to look beyond the initial pounds shed and consider the sustainability of the results and the likelihood of weight regain. Let's dive into each category, drawing insights from specific studies.
Diet-based Programs: High probability of weight regain
A systematic review published in the Journal of the American Medical Association found that while diet-based programs can lead to significant weight loss in the short term, maintaining those results over the long haul is a challenge. A study in the International Journal of Obesity revealed that participants regained an average of 77% of their lost weight within five years of completing a diet-based program, underscoring the difficulty of sustaining weight loss through diet alone.
Medications: A mixed bag, GLP-1 tends to perform better
The long-term effectiveness of weight loss medications is a mixed bag. In the XENDOS study, published in Diabetes Care, participants using Orlistat maintained a weight loss of 2.7 kg after four years, compared to a placebo group. However, the SEQUEL study, featured in the American Journal of Clinical Nutrition, found that participants using Phentermine/Topiramate maintained a weight loss of 10.5% after two years, showing promise for long-term effectiveness. The STEP 4 study, published in the Journal of the American Medical Association, demonstrated that Semaglutide helped participants maintain a weight loss of 17.4% after 68 weeks.
Surgeries: The longest-lasting approach
Bariatric surgeries have shown the most impressive long-term weight loss results. The landmark Swedish Obese Subjects (SOS) study, published in the New England Journal of Medicine, found that after 10 years, participants who underwent Gastric Bypass maintained an average weight loss of 25%, while those who had Adjustable Gastric Band maintained a 13.2% weight loss. A meta-analysis in the Journal of the American Medical Association reported that Biliopancreatic Diversion/Duodenal Switch (BPD/DS) resulted in an excess weight loss of 73.1% after more than five years.
Despite the long-term effectiveness of bariatric surgeries, weight regain can still occur. The SOS study found that after 15 years, Gastric Bypass patients regained an average of 12% of their lost weight, while Adjustable Gastric Band patients regained 25%. However, these regains are significantly lower compared to diet-based programs.
Which Approach is Best For Me?
The choice of weight loss approach depends on several factors, including an individual's starting weight, health status, and personal preferences. Here's a concise guide on the best fit for each approach:
- Diet-based Programs: Best for those with a BMI under 30, who prefer a structured eating plan, and are willing to make long-term lifestyle changes. These programs are widely accessible and relatively affordable, making them a good starting point for many.
- Medications: Suitable for those with a BMI over 30 or those with weight-related health conditions. Medications can be effective for those who struggle with appetite control or have reached a plateau with diet and exercise alone. However, they require medical supervision and can be costly.
- Surgeries: Reserved for those with severe obesity (BMI over 40) or a BMI over 35 with serious weight-related health issues. Surgeries offer the most dramatic and lasting results but come with the highest risks and costs. They also require a lifelong commitment to dietary changes and follow-up care.
Ultimately, the best approach is one that an individual can adhere to long-term, leading to sustainable weight loss and improved overall health. Consulting with a healthcare professional can help guide the decision-making process and ensure the chosen method is safe and appropriate for an individual's unique needs and circumstances.
Promising Weightloss Approaches in Research and Development
Several promising weight loss approaches are currently in various stages of research and development, offering potential new avenues for those seeking to manage their weight effectively. Here are three intriguing areas of exploration:
- Peptide-based therapies: Researchers are also exploring other peptides, such as PYY (peptide YY) and amylin analogs, which could be combined with GLP-1 agonists to enhance weight loss outcomes. As our understanding of these peptides grows, more targeted and effective medications may become available.
- Microbiome-based interventions: One approach involves fecal microbiota transplantation (FMT), where the gut bacteria from a lean, healthy donor are transferred to an individual with obesity. Early studies have shown promising results, with some participants experiencing significant weight loss following FMT. Another avenue of exploration is the development of targeted probiotics and prebiotics that could selectively promote the growth of beneficial bacteria associated with a healthy weight.
- Gene-targeted therapies: Advances in genetic research have revealed that certain genetic variations can influence an individual's susceptibility to obesity and their response to different weight loss interventions. Scientists are now exploring ways to target these specific genes to promote weight loss. One promising approach involves the use of CRISPR-Cas9, a powerful gene-editing tool that could potentially be used to "turn off" obesity-related genes or "turn on" genes associated with increased metabolism and fat burning. Another area of investigation is the development of gene therapies that could be delivered directly to fat cells, instructing them to burn stored energy more efficiently.
Frequently Asked Questions
Can our genes influence the effectiveness of different weight loss approaches, and if so, how might this impact personalized treatment plans?
AEmerging research suggests that genetic factors can indeed play a role in an individual's response to various weight loss interventions. Certain genetic variations may impact metabolism, appetite regulation, and even the way our bodies process and store fat.
How might the gut microbiome influence weight loss, and are there ways to optimize it for better results?
The gut microbiome, consisting of trillions of bacteria, has been shown to play a significant role in metabolism and weight regulation. Certain microbial imbalances have been linked to obesity and metabolic disorders. Interestingly, some studies suggest that the composition of the gut microbiome may influence an individual's response to different weight loss interventions.
Can technology like AI and machine learning help predict an individual's success with a particular weight loss approach?
As artificial intelligence (AI) and machine learning advance, there is growing interest in leveraging these technologies to predict an individual's success with specific weight loss interventions. By analyzing vast amounts of data, including demographic information, health metrics, behavioral patterns, and even genetic profiles, AI algorithms could potentially identify the most promising approach for a given individual.
Are there any emerging, cutting-edge weight loss therapies on the horizon that could revolutionize treatment options?
Researchers are continually exploring new and innovative approaches to weight loss, ranging from novel medications to advanced surgical techniques. For example, some studies are investigating the potential of gene therapy to target specific obesity-related genes, while others are exploring the use of stem cells to manipulate fat storage and metabolism. In the realm of surgery, less invasive techniques like endoscopic sleeve gastroplasty are being refined to reduce risks and improve outcomes.